CD8A and non-small cell lung carcinoma: Notable examples include CircIGF2BP3 in NSCLC, associated with poor prognosis by reducing CD8+ T cell immune infiltration and upregulating PKP3 expression via sponging miR-328-3p and miR-3173-5p, ultimately preventing PD-L1 degradation and promoting immune escape [110].